SKIP000713 |
SKIP ID |
SKIP000713 |
Organism(En) |
- |
Organism(Ja) |
- |
Cell Type(En) |
- |
Cell Type(Ja) |
- |
Cell Tissue(En) |
- |
Cell Tissue(Ja) |
- |
Cell Origin |
Normal |
Cell Name 1(En) |
UE6E7TC-4 |
Cell Name 1(Ja) |
UE6E7TC-4 |
Cell Name 2(En) |
- |
Cell Name 2(Ja) |
- |
Disease Name 1(Ja) |
- |
ICD Code 1 |
- |
Disease Name 1(En) |
- |
OMIM1 |
- |
Disease Name 2(Ja) |
- |
ICD Code 2 |
- |
Disease Name 2(En) |
- |
OMIM 2 |
- |
Disease Name 3(Ja) |
- |
ICD Code 3 |
- |
Disease Name 3(En) |
- |
OMIM 3 |
- |
Age |
- |
Age Range |
-- |
Sex |
-- |
Race(En) |
- |
Race(Ja) |
- |
Genetic Diagnosis |
-- |
Not Detected |
No |
Description(En) |
JCRB1137 Osteoblast-like cell like. Human bone marrow-derived mesenchymal stem cells which were infected with recombinant retroviruses expressing the E6, E7, and hTERT. |
Description(Ja) |
骨芽細胞様株, 間葉系幹細胞の性質を持つとされる, (C3H/He mouse) |
Cell Morphology |
fibroblast-like |
Grade |
-- |
Vector |
Retrovirus |
Transgene |
recombinant retroviruses expressing the E6, E7, and hTERT. |
Adhesiveness |
- |
Feeder |
-- |
Feeder Cell |
- |
Medium |
poweredby10. When the cultures reached subconfluence, the cells were harvested with 0.25% trypsin and 1mM EDTA and replated with one-half of harvested cells. |
Genome Editing |
- |
CO2 |
5% |
Mycoplasma |
- |
Detection of Contaminants Mycoplasma |
- |
Pluripotent Markers |
- |
Pluripotent Markers Assay |
- |
in vitro Differentiation |
- |
in vitro Differentiation Assay |
- |
in vivo Differentiation |
- |
in vivo Differentiation Assay |
- |
Other 1 Assay |
- |
Other 1 Assay Method |
- |
Other 2 Assay |
- |
Other 2 Assay Method |
- |
Other 3 Assay |
- |
Other 3 Assay Method |
- |
Karyotype |
- |
Karyotype Assay |
- |
Remaining Vector Detection |
- |
Remaining Vector Detection Assay |
- |
STR |
- |
HLA |
- |
Stem Cell Transcriptome analysis |
- |
Stem Cell Transcriptome analysis Assay |
- |
Author Name(En) |
Umezawa, Akihiro |
Author Name(Ja) |
梅澤 明弘 |
Author Organization(En) |
National Center for Child Health and Development |
Author Organization(Ja) |
国立成育医療研究センター研究所 |
Author Contact Email |
- |
PI Organization(En) |
- |
PI Organization(Ja) |
- |
PI Name(En) |
- |
PI Name(Ja) |
- |
PI Contact Email |
- |
Availability |
Not Available |
Provider Organization(En) |
National Institute of Biomedical Innovation. |
Provider Organization(Ja) |
独立行政法人医薬基盤研究所JCRB細胞バンク |
Provider Email |
- |
Provider URL |
http://cellbank.nibio.go.jp/~cellbank/cgi-bin/search_res_det.cgi?DB_NUM=1&ID=3593 |
Ethical Statement(En) |
- |
Ethical Statement(Ja) |
- |
Terms of Use(En) |
- |
Terms of Use(Ja) |
- |
PubMed ID |
15923633 |
DOI |
10.1128/MCB.25.12.5183-5195.2005 |
Title |
Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. |
Authors |
Mori T, Kiyono T, Imabayashi H, Takeda Y, Tsuchiya K, Miyoshi S, Makino H, Matsumoto K, Saito H, Ogawa S, Sakamoto M, Hata J, Umezawa A |
Journal |
Mol Cell Biol |
Year |
2005 |
Volume |
25 |
Issue |
12 |
Pages |
5183-95 |
URL |
http://www.ncbi.nlm.nih.gov/pubmed/15923633 |
Free input |
Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?Takeda Y,Mori T,Imabayashi H,Kiyono T,Gojo S,Miyoshi S,Hida N,Ita M,Segawa K,Ogawa S,Sakamoto M,Nakamura S,Umezawa A.,J Gene Med. 2004 Aug;6(8):833-45;PMID:15293342 |
Note |
- |